Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - SOLIGENIX, INC. | f8k040110ex99i_soligenix.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date of
Report (Date of Earliest Event Reported): April 1,
2010
Commission
File No. 000-16929
Soligenix,
Inc.
(Exact
name of small business issuer as specified in its charter)
DELAWARE
|
41-1505029
|
|||
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification Number)
|
|||
29
Emmons Drive,
Suite
C-10
Princeton,
NJ
|
08540
|
|||
(Address
of principal executive offices)
|
(Zip
Code)
|
|||
(609)
538-8200
|
||||
(Issuer’s
telephone number, including area code)
|
||||
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[ ] Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02. Results
of Operations and Financial Condition.
On April
1, 2010, Soligenix, Inc. (the Company), a late-stage biopharmaceutical company,
issued a press release announcing its results of operations for the year ended
December 31, 2009. A copy of the press release is attached as Exhibit
99.1 to this report. This information is not deemed to be “filed” for
the purposes of Section 18 of the Securities Exchange Act of 1934 and is not
incorporated by reference into any Securities Act registration statements.
Item
9.01. Financial
Statements and Exhibits.
(d)
Exhibits.
Exhibit
No.
|
Description
|
|
99.1
|
Press
release issued by the Company on April 1, 2010.
|
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Soligenix,
Inc.
|
||
April
1, 2010
|
by:
|
/s/ Christopher J.
Schaber
|
Christopher
J. Schaber, Ph.D.
|
||
President
and Chief Executive Officer
|
||
(Principal
Executive Officer)
|
||
EXHIBIT
INDEX
Exhibit
No.
|
Description
|
|
99.1
|
Press
release issued by the Company on April 1,
2010.
|